NeuroDex Pioneers New Multi-Pronged Biomarker for Neurodegenerative Diseases
Rather than a one-size-fits-all blood test that looks for a single pathology, NeuroDex is commercializing a novel scientific approach, based on the study of extracellular vesicles – that can decipher “mixed pathology” in dementia and lead to a more personalized treatment plan. The Challenge Whenever we write about a company in the Alzheimer’s Moonshot we…